Initiating Antiretroviral Therapy at a Patient’s First Clinic Visit: The RapIT Study

By  Sydney Rosen  Dr Mhairi Maskew  Matthew Fox  Cynthia Nyoni  Constance Mongwenyana  Given Malete  |  | 

The RapIT study was conducted from 2013 to 2015  at two clinics in Johannesburg, South Africa. It was a randomized controlled trial of rapid ART initiation that allowed patients to have treatment eligibility determined, all treatment preparation steps performed, and ARV medications dispensed on the day of their first HIV-related clinic visit. Although it took place at only two clinics, both in urban areas in a single province, the RapIT trial showed that it is possible to start nearly all patients on HIV treatment in a much shorter time frame than previously required, and that offering patients the chance to start ART during their first HIV-related clinic visit can be an effective strategy for improving health outcomes.

Publication details

PDF